Key result
Troponin T levels did not exceed the reference range in any of the 32 stroke patients despite elevated CK-MB in 34.4%, indicating that CK-MB elevations after stroke are likely noncardiac.
Why the study?
Does CK-MB elevation after stroke indicate myocardial injury as measured by troponin T?
Observational (n=54)
Does CK-MB elevation after stroke indicate myocardial injury as measured by troponin T?
Elevated CK-MB after stroke is likely noncardiac in origin, as troponin T levels remain normal.
Answers are grounded in this paper and cite their sources.
CK-MB elevations after stroke may not indicate myocardial injury; leaves open troponin T preference pending larger prospective studies.
Background and Purpose — Creatine kinase-MB (CK-MB) increases in some patients with stroke, with no clear evidence of an acute coronary syndrome. Its elevations have been suggested to represent a biological marker for stroke-related myocardial injury. Troponin T has superior sensitivity and specificity to CK-MB in revealing minor myocardial injury. Therefore, we studied troponin T levels after stroke to determine whether troponin T increases in parallel to CK-MB. Methods — We made daily measurements of CK-MB, myoglobin, total creatine kinase (total CK), and troponin T levels up to day 5 in 32 patients with large hemispheric infarction and with no history of coronary heart disease. The daily enzyme levels were compared with those of a control group of 22 patients with neurological diseases other than stroke. Results — Serum CK-MB, myoglobin, and total CK levels were elevated above the cutoff value in 11, 26, and 20 patients with stroke, respectively. These enzyme levels gradually increased within the first 3 days and declined afterward. Troponin T did not exceed the reference range in any patients. One patient had elevated myoglobin and 3 had elevated total CK in the control group. The difference between groups was significant for CK-MB, myoglobin, and total CK at various time points. Conclusions — Troponin T, a more specific biochemical marker of myocardial injury, does not increase after stroke. Normal troponin T along with elevated CK-MB signifies that CK-MB is not the biological marker for myocytolysis. CK-MB elevations in stroke patients are likely to be noncardiac in origin.
No takes yet. Share an insight, caveat, or question.
Ay et al. (2002) conducted an observational in Large hemispheric infarction (n=54). Large hemispheric infarction vs. Neurological diseases other than stroke was evaluated on Troponin T elevation above reference range. Troponin T levels did not exceed the reference range in any of the 32 stroke patients despite elevated CK-MB in 34.4%, indicating that CK-MB elevations after stroke are likely noncardiac.
Synapse has enriched 10 related papers. Consider them for comparative context: